Chemoinformaics analysis of 3,4-Dihydroexcelsin
| Molecular Weight | 496.597 | nRot | 4 |
| Heavy Atom Molecular Weight | 456.277 | nRig | 25 |
| Exact Molecular Weight | 496.267 | nRing | 5 |
| Solubility: LogS | -3.872 | nHRing | 2 |
| Solubility: LogP | 3.257 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 77.3097 |
| nHD | 4 | BPOL | 47.0723 |
| QED | 0.419 |
| Synth | 6.662 |
| Natural Product Likeliness | 3.344 |
| NR-PPAR-gamma | 0.039 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.543 |
| Pgp-sub | 0.996 |
| HIA | 0.053 |
| CACO-2 | -5.289 |
| MDCK | 0.000105798 |
| BBB | 0.07 |
| PPB | 0.764586 |
| VDSS | 0.846 |
| FU | 0.222644 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.85 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.702 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.017 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.196 |
| CL | 5.536 |
| T12 | 0.589 |
| hERG | 0.244 |
| Ames | 0.011 |
| ROA | 0.289 |
| SkinSen | 0.16 |
| Carcinogencity | 0.012 |
| EI | 0.011 |
| Respiratory | 0.918 |
| NR-Aromatase | 0.462 |
| Antiviral | Yes |
| Prediction | 0.762212 |